Top

Published in:

Open Access 01-10-2015 | Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

Mechanisms of Beta Cell Dysfunction Associated With Viral Infection

Authors: Antje Petzold, Michele Solimena, Klaus-Peter Knoch

Published in: Current Diabetes Reports | Issue 10/2015

Abstract

Type 1 diabetes (T1D) results from genetic predisposition and environmental factors leading to the autoimmune destruction of pancreatic beta cells. Recently, a rapid increase in the incidence of childhood T1D has been observed worldwide; this is too fast to be explained by genetic factors alone, pointing to the spreading of environmental factors linked to the disease. Enteroviruses (EVs) are perhaps the most investigated environmental agents in relationship to the pathogenesis of T1D. While several studies point to the likelihood of such correlation, epidemiological evidence in its support is inconclusive or in some instances even against it. Hence, it is still unknown if and how EVs are involved in the development of T1D. Here we review recent findings concerning the biology of EV in beta cells and the potential implications of this knowledge for the understanding of beta cell dysfunction and autoimmune destruction in T1D.

DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23:857–66. doi:10.1111/j.1464-5491.2006.01925.x.CrossRef

Patterson CC, Dahlquist GG, Gyürüs E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027–33. doi:10.1016/S0140-6736(09)60568-7.PubMedCrossRef

Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703–7. doi:10.1038/ng.381.PubMedCentralPubMedCrossRef

Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994;371:130–6. doi:10.1038/371130a0.PubMedCrossRef

Rønningen KS, Keiding N, Green A, et al. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia. 2001;44 Suppl 3:B51–9.PubMedCrossRef

Redondo MJ, Yu L, Hawa M, Mackenzie T, et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001;44:354–62. doi:10.1007/s001250051626.PubMedCrossRef

Hyttinen V, Kaprio J, Kinnunen L, et al. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes. 2003;52:1052–5.PubMedCrossRef

Bodansky HJ, Staines A, Stephenson C, et al. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ. 1992;304:1020–2.PubMedCentralPubMedCrossRef

Delli AJ, Lindblad B, Carlsson A, et al. Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies. Pediatr Diabetes. 2010;11:513–20. doi:10.1111/j.1399-5448.2010.00637.x.PubMedCrossRef

10.

Pak CY, Eun HM, McArthur RG, et al. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet. 1988;2:1–4.PubMedCrossRef

11.

Chikazawa K, Okusa H, Minakami H, et al. Acute onset of insulin-dependent diabetes mellitus caused by Epstein-Barr virus infection. Nippon Sanka Fujinka Gakkai Zasshi. 1985;37:453–6.PubMed

12.

Khakpour M, Nik-Akhtar B. Diabetes mellitus following a mumps epidemic. J Trop Med Hyg. 1975;78:262–3.PubMed

13.

Helmke K, Otten A, Willems W. Islet cell antibodies in children with mumps infection. Lancet. 1980;2:211–2.PubMedCrossRef

14.

Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes. 2000;49:1319–24.PubMedCrossRef

15.

Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet. 1971;2:332–4.PubMedCrossRef

16.

Craighead JE, McLane MF. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science. 1968;162:913–4.PubMedCrossRef

17.

Serreze DV, Ottendorfer EW, Ellis TM, et al. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes. 2000;49:708–11.PubMedCrossRef

18.

Drescher KM, Kono K, Bopegamage S, et al. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology. 2004;329:381–94. doi:10.1016/j.virol.2004.06.049.PubMedCrossRef

19.

Tracy S, Drescher KM, Chapman NM, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol. 2002;76:12097–111.PubMedCentralPubMedCrossRef

20.

Gamble DR, Kinsley ML, FitzGerald MG, et al. Viral antibodies in diabetes mellitus. Br Med J. 1969;3:627–30.PubMedCentralPubMedCrossRef

21.

Gamble DR, Taylor KW. Seasonal incidence of diabetes mellitus. Br Med J. 1969;3:631–3.PubMedCentralPubMedCrossRef

22.

Yoon JW, Austin M, Onodera T, et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979;300:1173–9. doi:10.1056/NEJM197905243002102.PubMedCrossRef

23.

Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet. 1985;1:1409–12.PubMedCrossRef

24.

Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 1995;44:652–7.PubMedCrossRef

25.

Green J, Casabonne D, Newton R. Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med. 2004;21:507–14. doi:10.1111/j.1464-5491.2004.01182.x.PubMedCrossRef

26.

Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet. 1995;346:221–3.PubMedCrossRef

27.

Andréoletti L, Hober D, Hober-Vandenberghe C, et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol. 1997;52:121–7.PubMedCrossRef

28.

Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004;47:225–39. doi:10.1007/s00125-003-1297-z.PubMedCrossRef

29.

Dotta F, Censini S, van Halteren AGS, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A. 2007;104:5115–20. doi:10.1073/pnas.0700442104.PubMedCentralPubMedCrossRef

30.

Richardson SJ, Willcox A, Bone AJ, et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009;52:1143–51. doi:10.1007/s00125-009-1276-0.PubMedCrossRef

31.

Yeung W-CG, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35.PubMedCentralPubMedCrossRef

32.

Lee H-S, Briese T, Winkler C, et al. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia. 2013;56:1705–11. doi:10.1007/s00125-013-2924-y.PubMedCentralPubMedCrossRef

33.••

Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015;64:1682–7. doi:10.2337/db14-1370. This study provides evidence for EVs in pancreatic biopsy tissue at diagnosis of T1D.PubMedCrossRef

34.

Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005;48:290–3. doi:10.1007/s00125-004-1624-z.PubMedCrossRef

35.

Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009;58:2285–91. doi:10.2337/db09-0091.PubMedCentralPubMedCrossRef

36.••

Laitinen OH, Honkanen H, Pakkanen O, et al. Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes. Diabetes. 2014;63:446–55. doi:10.2337/db13-0619. ere CVBs are clustered into risk and protective viruses and immunological cross-protection is proposed.PubMedCrossRef

37.•

Oikarinen S, Tauriainen S, Hober D, et al. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes. 2014;63:655–62. doi:10.2337/db13-0620. In this study data is presented to support the presumable role of CVB1 as diabetogenic virus.PubMedCrossRef

38.

Lin H-C, Wang C-H, Tsai F-J, et al. Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study. Diabetologia. 2015;58:79–86. doi:10.1007/s00125-014-3400-z.PubMedCrossRef

39.

Knowles N, Hovi T, Hyypiä T, et al. Picornaviridae. Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses, San Diego: Elsevier; 2012, p. 855–80.

40.

Ehrenfeld E, Domingo E, Roos RP, editors. The Picornaviruses. Washington, D.C.: ASM Press; 2010.

41.

Tracy S, Oberste SM, Drescher KM. Group B Coxsackieviruses. Current Topics in Microbiology and Immunology, vol. 323. Berlin Heidelberg: Springer-Verlag; 2008.

42.

Frisk G, Diderholm H. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release. Int J Exp Diabetes Res. 2000;1:165–75.PubMedCentralPubMedCrossRef

43.

Hodik M, Lukinius A, Korsgren O, et al. Tropism analysis of two Coxsackie B5 strains reveals virus growth in human primary pancreatic islets but not in exocrine cell clusters in vitro. O Virol J. 2013;7:49–56. doi:10.2174/1874357901307010049.CrossRef

44.•

Marroqui Esclapez L, Lopes M, Dos Santos RS, et al. Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic α and β cells. Elife. 2015;4. doi:10.7554/eLife.06990. Here a possible reason for differences between alpha and beta cells in the clearance of viral infections and susceptibility to autoimmunity is provided.

45.

Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320–3.PubMedCrossRef

46.

Shafren DR, Bates RC, Agrez MV, et al. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol. 1995;69:3873–7.PubMedCentralPubMed

47.

Chehadeh W, Kerr-Conte J, Pattou F, et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol. 2000;74:10153–64.PubMedCentralPubMedCrossRef

48.

Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell. 2006;124:119–31. doi:10.1016/j.cell.2005.10.035.PubMedCrossRef

49.

Patel KP, Coyne CB, Bergelson JM. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J Virol. 2009;83:11064–77. doi:10.1128/JVI.01016-09.PubMedCentralPubMedCrossRef

50.

Lloyd RE. Translational control by viral proteinases. Virus Res. 2006;119:76–88. doi:10.1016/j.virusres.2005.10.016.PubMedCrossRef

51.

Hellen CU, Witherell GW, Schmid M, et al. A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A. 1993;90:7642–6.PubMedCentralPubMedCrossRef

52.

Lamphear BJ, Yan R, Yang F, et al. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J Biol Chem. 1993;268:19200–3.PubMed

53.

Sommergruber W, Ahorn H, Klump H, et al. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology. 1994;198:741–5.PubMedCrossRef

54.

De Breyne S, Bonderoff JM, Chumakov KM, et al. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology. 2008;378:118–22. doi:10.1016/j.virol.2008.05.019.PubMedCentralPubMedCrossRef

55.

Joachims M, Van Breugel PC, Lloyd RE. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol. 1999;73:718–27.PubMedCentralPubMed

56.

Kerekatte V, Keiper BD, Badorff C, et al. Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? J Virol. 1999;73:709–17.PubMedCentralPubMed

57.

Modrow S. Viruses with single-stranded, positive-sense RNA genomes. Molecular Virology, Berlin Heidelberg: Springer-Verlag; 2013

58.

Xin L, Xiao Z, Ma X, et al. Coxsackievirus B3 induces crosstalk between autophagy and apoptosis to benefit its release after replicating in autophagosomes through a mechanism involving caspase cleavage of autophagy-related proteins. Infect Genet Evol. 2014;26:95–102. doi:10.1016/j.meegid.2014.05.005.PubMedCrossRef

59.

Roivainen M, Ylipaasto P, Savolainen C, et al. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia. 2002;45:693–702. doi:10.1007/s00125-002-0805-x.PubMedCrossRef

60.

Colli ML, Nogueira TC, Allagnat F, et al. Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathog. 2011;7:e1002267. doi:10.1371/journal.ppat.1002267.PubMedCentralPubMedCrossRef

61.•

Richardson SJ, Leete P, Bone AJ, et al. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia. 2013;56:185–93. doi:10.1007/s00125-012-2745-4. This study supports previous data for activation of antiviral response and enhanced apoptosis in infected beta cells.PubMedCrossRef

62.

Roivainen M, Rasilainen S, Ylipaasto P, et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab. 2000;85:432–40. doi:10.1210/jcem.85.1.6306.PubMed

63.••

Knoch K-P, Nath-Sain S, Petzold A, et al. PTBP1 is required for glucose-stimulated cap-independent translation of insulin granule proteins and Coxsackieviruses in beta cells. Mol Metab. 2014;3:518–30. doi:10.1016/j.molmet.2014.05.002. Here evidence for cap-independent PTBP1-mediated translation of SG proteins and CVB RNA is presented. Hence, translation of SG protein is not inhibit upon CVB infection and therefore is not the cause for reduced SG stores and insulin secretion.PubMedCentralPubMedCrossRef

64.••

Ylipaasto P, Smura T, Gopalacharyulu P, et al. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction. Diabetologia. 2012;55:3273–83. doi:10.1007/s00125-012-2713-z. In this study virus strain-specific changes in gene expression of infected beta cells are addressed for pro-inflammatory response and necrosis.PubMedCrossRef

65.

Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia. 2005;48:1510–22. doi:10.1007/s00125-005-1839-7.PubMedCrossRef

66.

Skog O, Korsgren O, Frisk G. Modulation of innate immunity in human pancreatic islets infected with enterovirus in vitro. J Med Virol. 2011;83:658–64. doi:10.1002/jmv.21924.PubMedCrossRef

67.

Olsson A, Johansson U, Korsgren O, et al. Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans. Biochem Biophys Res Commun. 2005;330:571–6. doi:10.1016/j.bbrc.2005.03.016.PubMedCrossRef

68.

Schulte BM, Lanke KHW, Piganelli JD, et al. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes. 2012;61:2030–6. doi:10.2337/db11-1547.PubMedCentralPubMedCrossRef

69.

Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet. 1987;2:1423–7.PubMedCrossRef

70.

Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012;209:51–60. doi:10.1084/jem.20111187.PubMedCentralPubMedCrossRef

71.

Rasilainen S, Ylipaasto P, Roivainen M, et al. Mechanisms of coxsackievirus B5 mediated beta-cell death depend on the multiplicity of infection. J Med Virol. 2004;72:586–96. doi:10.1002/jmv.20043.PubMedCrossRef

72.

Willcox A, Richardson SJ, Bone AJ, et al. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia. 2011;54:2417–20. doi:10.1007/s00125-011-2192-7.PubMedCrossRef

73.

Yap IS, Giddings G, Pocock E, et al. Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J Gen Virol. 2003;84:3051–68.PubMedCrossRef

74.

Gallagher GR, Brehm MA, Finberg RW, et al. Viral infection of engrafted human islets leads to diabetes. Diabetes. 2015;64:1358–69. doi:10.2337/db14-1020.PubMedCrossRef

75.

Craig ME, Nair S, Stein H, et al. Viruses and type 1 diabetes: a new look at an old story. Pediatr Diabetes. 2013;14:149–58. doi:10.1111/pedi.12033.PubMed

76.

Seewaldt S, Thomas HE, Ejrnaes M, et al. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes. 2000;49:1801–9.PubMedCrossRef

77.

Stassi G, De Maria R, Trucco G, et al. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med. 1997;186:1193–200.PubMedCentralPubMedCrossRef

78.

Horwitz MS, Bradley LM, Harbertson J, et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 1998;4:781–5.PubMedCrossRef

79.

Von Herrath MG, Allison J, Miller JF, et al. Focal expression of interleukin-2 does not break unresponsiveness to “self” (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest. 1995;95:477–85. doi:10.1172/JCI117688.CrossRef

80.

Holz A, Brett K, Oldstone MB. Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes. J Clin Invest. 2001;108:1749–58. doi:10.1172/JCI13915.PubMedCentralPubMedCrossRef

81.

Atkinson MA, Bowman MA, Campbell L, et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994;94:2125–9. doi:10.1172/JCI117567.PubMedCentralPubMedCrossRef

82.

Richter W, Mertens T, Schoel B, et al. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med. 1994;180:721–6.PubMedCrossRef

83.

Schloot NC, Willemen SJ, Duinkerken G, et al. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum Immunol. 2001;62:299–309.PubMedCrossRef

84.

Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med. 1998;4:231–9.PubMedCentralPubMed

85.

Honeyman MC, Stone NL, Falk BA, et al. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol. 2010;184:2204–10. doi:10.4049/jimmunol.0900709.PubMedCrossRef

86.

Härkönen T, Lankinen H, Davydova B, et al. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol. 2002;66:340–50.PubMedCrossRef

87.

Yin H, Berg A-K, Westman J, et al. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology. J Med Virol. 2002;68:544–57. doi:10.1002/jmv.10236.PubMedCrossRef

88.

Tracy S, Smithee S, Alhazmi A, et al. Coxsackievirus can persist in murine pancreas by deletion of 5’ terminal genomic sequences. J Med Virol. 2015;87:240–7. doi:10.1002/jmv.24039.PubMedCrossRef

89.

Oikarinen M, Tauriainen S, Honkanen T, et al. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol. 2008;151:71–5. doi:10.1111/j.1365-2249.2007.03529.x.PubMedCentralPubMedCrossRef

90.

Oikarinen M, Tauriainen S, Oikarinen S, et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes. 2012;61:687–91. doi:10.2337/db11-1157.PubMedCentralPubMedCrossRef

91.

Schulte BM, Bakkers J, Lanke KHW, et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol. 2010;23:99–104. doi:10.1089/vim.2009.0072.PubMedCrossRef

92.

Brilot F, Jaïdane H, Geenen V, et al. Coxsackievirus B4 infection of murine foetal thymus organ cultures. J Med Virol. 2008;80:659–66. doi:10.1002/jmv.21016.PubMedCrossRef

93.

Jaïdane H, Caloone D, Lobert P-E, et al. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J Virol. 2012;86:11151–62. doi:10.1128/JVI.00726-12.PubMedCentralPubMedCrossRef

94.

Henke A, Launhardt H, Klement K, et al. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol. 2000;74:4284–90.PubMedCentralPubMedCrossRef

95.

Gradi A, Svitkin YV, Imataka H, et al. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci U S A. 1998;95:11089–94.PubMedCentralPubMedCrossRef

96.

Seipelt J, Liebig HD, Sommergruber W, et al. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J Biol Chem. 2000;275:20084–9.PubMedCrossRef

97.

Wang B, Xi X, Lei X, et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013;9:e1003231. doi:10.1371/journal.ppat.1003231.PubMedCentralPubMedCrossRef

98.

Feng Q, Langereis MA, Lork M, et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol. 2014;88:3369–78. doi:10.1128/JVI.02712-13.PubMedCentralPubMedCrossRef

99.

Gustin KE, Sarnow P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 2001;20:240–9. doi:10.1093/emboj/20.1.240.PubMedCentralPubMedCrossRef

100.

Park N, Katikaneni P, Skern T, et al. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J Virol. 2008;82:1647–55. doi:10.1128/JVI.01670-07.PubMedCentralPubMedCrossRef

101.

Calandria C, Irurzun A, Barco A, et al. Individual expression of poliovirus 2Apro and 3Cpro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Res. 2004;104:39–49. doi:10.1016/j.virusres.2004.02.042.PubMedCrossRef

102.

Shi J, Wong J, Piesik P, et al. Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling. Autophagy. 2013;9:1591–603. doi:10.4161/auto.26059.PubMedCrossRef

103.

Rust RC, Landmann L, Gosert R, et al. Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J Virol. 2001;75:9808–18. doi:10.1128/JVI.75.20.9808-9818.2001.PubMedCentralPubMedCrossRef

104.

Wang J, Wu Z, Jin Q. COPI is required for enterovirus 71 replication. PLoS ONE. 2012;7:e38035. doi:10.1371/journal.pone.0038035.PubMedCentralPubMedCrossRef

105.

De Jong AS, Wessels E, Dijkman HBPM, et al. Determinants for membrane association and permeabilization of the coxsackievirus 2B protein and the identification of the Golgi complex as the target organelle. J Biol Chem. 2003;278:1012–21. doi:10.1074/jbc.M207745200.PubMedCrossRef

106.

Van Kuppeveld FJ, Hoenderop JG, Smeets RL, et al. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J. 1997;16:3519–32. doi:10.1093/emboj/16.12.3519.PubMedCentralPubMedCrossRef

107.

De Jong AS, Visch H-J, de Mattia F, et al. The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi. J Biol Chem. 2006;281:14144–50. doi:10.1074/jbc.M511766200.PubMedCrossRef

108.

Belov GA, Fogg MH, Ehrenfeld E. Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J Virol. 2005;79:7207–16. doi:10.1128/JVI.79.11.7207-7216.2005.PubMedCentralPubMedCrossRef

109.

Wessels E, Duijsings D, Niu T-K, et al. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell. 2006;11:191–201. doi:10.1016/j.devcel.2006.06.005.PubMedCrossRef

110.

Belov GA, Altan-Bonnet N, Kovtunovych G, et al. Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. J Virol. 2007;81:558–67. doi:10.1128/JVI.01820-06.PubMedCentralPubMedCrossRef

111.

Deitz SB, Dodd DA, Cooper S, et al. MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci U S A. 2000;97:13790–5. doi:10.1073/pnas.250483097.PubMedCentralPubMedCrossRef

112.

Li W, Ross-Smith N, Proud CG, et al. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site. FEBS Lett. 2001;507:1–5.PubMedCrossRef

113.

Kuyumcu-Martinez NM, Joachims M, Lloyd RE. Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease. J Virol. 2002;76:2062–74.PubMedCentralPubMedCrossRef

114.

Joachims M, Harris KS, Etchison D. Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4. Virology. 1995;211:451–61. doi:10.1006/viro.1995.1427.PubMedCrossRef

115.

Lei X, Han N, Xiao X, et al. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J Virol. 2014;88:9830–41. doi:10.1128/JVI.01425-14.PubMedCentralPubMedCrossRef

116.

Xiang Z, Li L, Lei X, et al. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J Virol. 2014;88:6650–9. doi:10.1128/JVI.03138-13.PubMedCentralPubMedCrossRef

117.

Mukherjee A, Morosky SA, Delorme-Axford E, et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011;7:e1001311. doi:10.1371/journal.ppat.1001311.PubMedCentralPubMedCrossRef

118.

Back SH, Kim YK, Kim WJ, et al. Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro). J Virol. 2002;76:2529–42.PubMedCentralPubMedCrossRef

119.

Perera R, Daijogo S, Walter BL, et al. Cellular protein modification by poliovirus: the two faces of poly(rC)-binding protein. J Virol. 2007;81:8919–32. doi:10.1128/JVI.01013-07.PubMedCentralPubMedCrossRef

120.

Clark ME, Hämmerle T, Wimmer E, et al. Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J. 1991;10:2941–7.PubMedCentralPubMed

121.

Clark ME, Lieberman PM, Berk AJ, et al. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol. 1993;13:1232–7.PubMedCentralPubMedCrossRef

122.

Weidman MK, Sharma R, Raychaudhuri S, et al. The interaction of cytoplasmic RNA viruses with the nucleus. Virus Res. 2003;95:75–85.PubMedCrossRef

123.

Barco A, Feduchi E, Carrasco L. Poliovirus protease 3C(pro) kills cells by apoptosis. Virology. 2000;266:352–60. doi:10.1006/viro.1999.0043.PubMedCrossRef

124.

Zhang H, Cong H, Song L, et al. The nuclear protein Sam68 is redistributed to the cytoplasm and is involved in PI3K/Akt activation during EV71 infection. Virus Res. 2014;180:1–11. doi:10.1016/j.virusres.2013.11.020.PubMedCrossRef

125.

Rozovics JM, Chase AJ, Cathcart AL, et al. Picornavirus modification of a host mRNA decay protein. MBio. 2012;3:e00431–00412. doi:10.1128/mBio.00431-12.

126.

Chase AJ, Daijogo S, Semler BL. Inhibition of poliovirus-induced cleavage of cellular protein PCBP2 reduces the levels of viral RNA replication. J Virol. 2014;88:3192–201. doi:10.1128/JVI.02503-13.PubMedCentralPubMedCrossRef

127.

Belov GA, Habbersett C, Franco D, et al. Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication. J Virol. 2007;81:9259–67. doi:10.1128/JVI.00840-07.PubMedCentralPubMedCrossRef

Title: Mechanisms of Beta Cell Dysfunction Associated With Viral Infection
Authors: Antje Petzold
Michele Solimena
Klaus-Peter Knoch
Publication date: 01-10-2015
Publisher: Springer US
Published in: Current Diabetes Reports / Issue 10/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0654-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Mechanisms of Beta Cell Dysfunction Associated With Viral Infection

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2015

Dual Renin-Angiotensin-Aldosterone System Inhibition for the Treatment of Diabetic Kidney Disease: Adverse Effects and Unfulfilled Promise

Overlap in Eating Disorders and Obesity in Adolescence

Hypoglycemia and Comorbidities in Type 2 Diabetes

Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion

The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions

Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient—An Evidence-based Approach

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page